A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

NCT01609140 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: MPSK3169A
DRUG: MPSK3169A
DRUG: MPSK3169A
DRUG: MPSK3169A
DRUG: MPSK3169A
DRUG: Placebo

Sponsor

Genentech, Inc.